Series A - Biorithm

Series A - Biorithm

Investment Firm

Overview

Biorithm has developed a remote maternal-fetal care platform to deliver home care for pregnant and postnatal patients.

Announced Date

Dec 18, 2023

Closed on Date

Jan 19, 2024

Funding Type

Series A

Highlights

Location

Asia

Social

Investor Lead

Adaptive Capital Partners

Adaptive Capital Partners

Adaptive Capital Partners is a early_stage_venture and seed firm.

Participant Investors

2

Investor Name
Participant InvestorAustralian Medical Angels
Participant InvestorAdaptive Capital Partners

Round Details and Background

Biorithm raised $3500000 on 2023-12-18 in Series A

Biorithm has developed a remote maternal-fetal care platform to deliver home care for pregnant and postnatal patients.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 18, 2023
Series A - Biorithm
3-3.5M
Feb 29, 2016
Non Equity Assistance - Biorithm
1-undefined